Company / Tangible Book Value per Share
Revolution Medicines, Inc. Tangible Book Value per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Tangible Book Value per Share
$8.70
FY2025
5-year range
-$2.51 / $20.04
FY2021-FY2025
Trend
-36.4%
vs FY2024
Sector context
#59 of 209
Health Care
What the data says
At $8.70, Revolution Medicines, Inc.'s tangible book value per share ranks #59 of 209 in the Health Care sector. Declined from $20.04 to $8.70 over the past 2 years.
Based on SEC 10-K filings.
8.70 in FY2025 with a 3-year CAGR of +11.9%.
Declined from $20.04 to $8.70 over the past 2 years.
Health Care sector context is included.
Tangible Book Value per Share over time
Growth rates
- 3-Year CAGR
- +11.9%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#59 of 209 in Health CareTop 28% of 209This company $8.70 Sector average $119.74
▼
-92.7% below sector average
Key checks
Key Insights
- In FY2025, tangible book value per share decreased 36.4% year-over-year.
- Ranks #59 out of 209 companies in the Health Care sector.
- Peak tangible book value per share was recorded in FY2023.
- Lowest tangible book value per share in the period was in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -1.10 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Tangible Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $8.70 | -36.4% |
| FY2024 | $13.67 | -31.8% |
| FY2023 | $20.04 | +222.9% |
| FY2022 | $6.21 | +347.2% |
| FY2021 | -$2.51 | +93.3% |
| FY2020 | -$37.37 | +38.0% |
| FY2019 | -$60.30 | -27.8% |
| FY2018 | -$47.16 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026